Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $1.9 million.

  • Lifecore Biomedical, Inc. \De\'s Depreciation & Amortization (CF) fell 496.52% to $1.9 million in Q2 2025 from the same period last year, while for May 2025 it was $8.0 million, marking a year-over-year increase of 91.78%. This contributed to the annual value of $8.0 million for FY2025, which is 91.78% up from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Depreciation & Amortization (CF) stood at $1.9 million for Q2 2025, which was down 496.52% from $2.1 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s 5-year Depreciation & Amortization (CF) high stood at $5.9 million for Q4 2021, and its period low was $1.8 million during Q4 2023.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Depreciation & Amortization (CF) averaged around $3.2 million, with its median value being $2.8 million (2022).
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Depreciation & Amortization (CF) skyrocketed by 2550.8% in 2021 and then crashed by 5041.32% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Depreciation & Amortization (CF) (Quarter) stood at $5.9 million in 2021, then crashed by 50.41% to $2.9 million in 2022, then tumbled by 39.93% to $1.8 million in 2023, then grew by 15.74% to $2.0 million in 2024, then dropped by 6.36% to $1.9 million in 2025.
  • Its Depreciation & Amortization (CF) was $1.9 million in Q2 2025, compared to $2.1 million in Q1 2025 and $2.0 million in Q4 2024.